All Fields
Computer Science
Medicine
FAQ
Contact
Sign in
EG 626
National Institutes of Health
Watch Topic
Topic mentions per year
Topic mentions per year
1979-1985
0
1
1979
1985
Related topics
Related topics
1 relation
Broader (1)
phthalazinol
Related mentions per year
Related mentions per year
1976-2005
1970
1980
1990
2000
2010
EG 626
phthalazinol
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1985
1985
Effects of 7-ethoxycarbonyl-4-hydroxymethyl-6,8-dimethyl-1(2H)-phthalazinone (EG 626), a new phosphodiesterase inhibitor, on the cardiovascular system of the dog.
Yui Furuta
,
Tomonari Takahira
,
Motoi Ueno
Arzneimittel-Forschung
1985
7-Ethoxycarbonyl-4-hydroxymethyl-6,8-dimethyl-1(2H)-phthalazinone (EG 626) (0.3-3 mg/kg i.v.), a new cyclic AMP phosphodiesterase…
(More)
Is this relevant?
1980
1980
Effects of phthalazinol (EG 626) and pyridinolcarbamate (Anginin) on lipolytic enzyme activities in rat adipose tissue -in vivo and in vitro-.
Takako Tomita
,
Isamu Yonekura
,
Y Shirasaki
,
Eiko Hayashi
,
Fujio Numano
Japanese journal of pharmacology
1980
Effects of Phthalazinol (EG 626), a cyclic AMP phosphodiesterase inhibitor, a thromboxane A2 antagonist and an…
(More)
Is this relevant?
1979
1979
Effects of phthalazinol (EG 626) on arterial lipolytic enzyme activities in the rat.
Takako Tomita
,
Isamu Yonekura
,
Y Shirasaki
,
Eiko Hayashi
,
Fujio Numano
Paroi arterielle
1979
Phthalazinol (EG 626), a thromboxane A2 antagonist and cyclic AMP phosphodiesterase inhibitor, has been shown to prevent the…
(More)
Is this relevant?